Trials / Not Yet Recruiting
Not Yet RecruitingNCT06093594
Investigating Participation Patterns Among Stage IV Melanoma Patients
Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2026-11-01
- First posted
- 2023-10-23
- Last updated
- 2023-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06093594. Inclusion in this directory is not an endorsement.